Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
TOP STORIES — Diabetes News and Research
Should We Convert our Patients to Concentrated Insulins?
Exenatide Reduces Risk of MACE for Type 2 Diabetes Patients
Pre-prandial Insulin & Meal Routine Can Help Children with Type 1
MOST POPULAR ARTICLES OF THE MONTH
#1 Intermittent Fasting Beneficial for Weight Loss and Glycemic Control
#2 Updated Consensus Report on Diabetic Nutrition Therapy
#3 Preventing Type 2 Diabetes through Vitamin D3 Supplementation
Editor's Note
When I was working as an insulin pump trainer we would have patients who needed upwards of 200 units a day. These patients would have to change the cartridge in their pump every couple of days rather than the normal 3-5 days most patients could do.
One of our solutions was to convert these patients to U-500 insulin. However, since this insulin was 5 times as strong, there was always the fear that hypoglycemia could occur, and many prescribers were not comfortable converting carb ratios and correction factors.
Now that we have insulins with only 2 to 3 times the potency, does it make more sense to use these in continuous delivery devices?
Kassey James, Pharm.D.Candidate, LECOM School of Pharmacy, has an overview of newer data on concentrated insulin and why it may be time to use in insulin pumps.
Dave Joffe
Editor-in-chief
TOP STORIES -- Diabetes News and Research
Concentrated insulins are no longer just for patients who have obesity or insulin resistance.
Exenatide joins trend of GLP-1 agonists showing benefit for patients with established CVD.
Does giving children with type 1 diabetes insulin before each meal help them lower their HbA1c?
About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.